GHK-Cu: Copper Tripeptide Gene Modulation, Collagen Matrix Synthesis & Cellular Viability

GHK-Cu (molecular formula C14H22CuN6O4, molecular weight 401.91 Da) exists as a stoichiometric 1:1 coordination complex between the tripeptide glycyl-L-histidyl-L-lysine and copper(II). The copper atom is tetracoordinated in a square-planar geometry by: (1) the amino-terminal nitrogen of glycine; (2) the deprotonated amide nitrogen of the Gly-His peptide bond; (3) the deprotonated amide nitrogen of the His-Lys peptide bond; and (4) the imidazole nitrogen atom (N-pi) of the histidine side-chain.

This square-planar coordination creates a thermodynamic stability constant of log K = 16.4, which matches the copper affinity of human serum albumin (log K = 16.2). As a result, GHK can readily exchange Cu(II) with albumin and transport it safely through the circulation without releasing free, unchelated copper ions that could catalyze toxic hydroxyl radical generation via Fenton-type reactions.

Spectrophotometric analysis of the aqueous complex reveals a characteristic d-d transition absorption maximum at 605 nm, imparting a vibrant royal blue color that serves as a direct analytical indicator of complete 1:1 copper stoichiometric chelation.

Using the Broad Institute's Connectivity Map (CMap) genomic database, Pickart and Margolina (Int J Mol Sci 2018) revealed that GHK-Cu significantly modulates the expression of 4,192 human genes (2,014 upregulated, 2,178 downregulated) at physiological concentrations (10^-9 to 10^-8 M).

Crucially, GHK shifts the genomic expression pattern of aged or senescent human fibroblasts back toward that of youthful, undamaged cells. Genes involved in DNA excision repair (such as OGG1, ERCC1, and XPA) are significantly upregulated, enhancing the cell's capacity to repair oxidative DNA damage. Concurrently, antioxidant defense genes including Cu/Zn superoxide dismutase (SOD1), catalase, and glutathione S-transferase are activated.

In contrast, pro-inflammatory and pro-fibrotic signaling cascades are suppressed: GHK-Cu downregulates transforming growth factor-beta (TGF-beta1), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6), thereby preventing unregulated extracellular scar deposition and chronic sterile tissue inflammation.

In dermal fibroblast culture models, GHK-Cu stimulates the biosynthesis of pro-collagen Type I and pro-collagen Type III by approximately 70% compared to untreated controls. In comparative head-to-head in vitro studies, GHK-Cu stimulated collagen synthesis more potently than both all-trans retinoic acid (retinoids) and ascorbic acid (vitamin C) without inducing cytotoxicity, erythema, or barrier disruption.

Equally important is GHK-Cu's capacity to induce decorin synthesis. Decorin is a small leucine-rich proteoglycan that binds to specific domains on collagen fibrils, regulating fibrillogenesis and ensuring uniform, parallel fiber diameter. By elevating decorin expression, GHK-Cu prevents the chaotic, cross-linked, disorganized collagen bundles characteristic of keloid and hypertrophic scar tissue, promoting functional, pliable tissue architecture.

GHK-Cu also restores the balance between extracellular matrix synthesis and degradation by upregulating matrix metalloproteinases (MMP-1 and MMP-2) to clear damaged, glycation-crosslinked collagen, while simultaneously elevating tissue inhibitor of metalloproteinases 1 (TIMP-1) to protect newly synthesized structural proteins from excessive proteolytic digestion.

Pure GHK-Cu is supplied as an intensely blue, crystalline lyophilized powder. The chemical composition requires precise 1:1 molarity between GHK free base and Cu2+; excess unchelated copper produces a green tint, while copper deficiency results in a pale blue or white color.

Reconstitution protocol: for a standard 50.0 mg vial, the addition of 5.0 mL of Bacteriostatic Water USP (0.9% benzyl alcohol) or Sterile Water for Injection yields a stock concentration of 10.0 mg/mL (10,000 mcg/mL). For micro-dosing models, adding 10.0 mL diluent yields a 5.0 mg/mL solution.

Syringe calibration on a standard U-100 syringe (100 units = 1.0 mL; 1 unit = 0.01 mL = 100 mcg GHK-Cu at 10 mg/mL): a research dose of 1,000 mcg (1.0 mg) corresponds to 10 units (0.10 mL); a 2,000 mcg (2.0 mg) dose corresponds to 20 units (0.20 mL). Reconstitution is virtually instantaneous upon solvent contact, forming an optically transparent, deep blue solution with pH between 6.0 and 7.2.

Storage parameters: Lyophilized solid vials remain stable at -20°C for up to 36 months, or 2°C–8°C for 24 months. Reconstituted solutions containing 0.9% benzyl alcohol must be stored refrigerated at 2°C–8°C away from strong oxidizing agents and light, remaining chemically stable for 28 days.

GHK-Cu possesses an extensive human and animal safety history spanning over 40 years of dermatological and wound care research. Because GHK is an endogenous component of human plasma, saliva, and urine, it exhibits virtually no systemic toxicity at physiological or pharmacological research concentrations.

In human patch testing and repeat insult patch tests (RIPT), topical GHK-Cu formulations up to 3% concentration produced no primary dermal irritation, allergic contact sensitization, or phototoxicity. Systemic LD50 in animal studies exceeds 1,000 mg/kg parenterally.

Furthermore, extensive in vitro Ames mutagenicity testing and chromosomal aberration assays have verified that GHK-Cu is non-mutagenic, non-clastogenic, and non-carcinogenic. Because bound copper is firmly sequestered within the square-planar chelate, systemic administration does not perturb systemic copper homeostasis or elevate free plasma copper levels.